Microparticles and nanoparticles made up of hydrophobized polysaccharides and an alpha-cyclodextrine
Microparticles and nanoparticles of hydrophobized polysaccharide and an alpha-cyclodextrin, obtained by self-association in an aqueous medium, the hydrophobized polysaccharide being obtained by grafting of alkyl chains derived from fatty acids, by an acylation reaction. These microparticles and nanoparticles constitute systems used for encapsulating substances of interest, in particular in the pharmaceutical field, and vectorization thereof for therapeutic purposes.
1. An inclusion complex formed by interaction in solvent between at least:
one polysaccharide selected from the group consisting of chitosan, dextran, hyaluronic acid, amylose, amylopectin, pullulan, heparin, chitin, heparan sulphate, dermatan sulphate, keratan sulphate, chondroitin sulphate, cellulose sulphate, dextran sulphate, dextrin sulphate, starch, pectin, the alginates, the carrageenans, fucan, curdlan, xylan, polyguluronic acid, xanthan, arabinan, and polymannuronic acid, said polysaccharide comprising hydrophobic groups selected from linear or branched alkyl groups containing from 2 to 1000 carbon atoms, or linear or branched alkenyl groups, which contain at least one C═C double bond, said hydrophobic groups being bound covalently to said polysaccharide such that said polysaccharide is amphiphilic, and
one α-cyclodextrin (CD) in the form of monomer,
wherein the polysaccharide and the cyclodextrin are bound non-covalently, and
wherein the polysaccharide and the cyclodextrin are present in a ratio of concentration of the cyclodextrin in g/L of the solvent to concentration of polysaccharide in g/L of the solvent in a range from 3.3 to 40.
2. The inclusion complex according to claim 1 , wherein the polysaccharide is composed of at least 3 saccharide units, the polysaccharide having a molecular weight in the range from 100 Da to 1,000,000 kDa, and wherein the polysaccharide has a degree of substitution with the hydrophobic groups from 0.001 to 100%.
3. The inclusion complex according to claim 1 , wherein:
the polysaccharide is a chitosan bearing hydrophobic groups at the level of oxygen atoms originating from the —OH groups and/or from the —CH 2 OH groups fixed to the chitosan ring, and having the formula
in which
R represents
a hydrogen atom, or
a group of formula
in which
R 4 represents the hydrophobic group and is selected from:
a linear or branched alkyl group containing from 1 to 1000 carbon atoms, and a linear or branched alkenyl group containing 2 to 1000 carbon atoms and containing at least one C═C double bond, provided that R represents at least one group of formula
m represents the number of D-glucosamine units,
n represents the number of N-acetyl-D-glucosamine units, provided that the degree of deacetylation (DDA) representing the percentage of m relative to the total number of units is greater than 50%,
and the α-cyclodextrin CD has the formula
in which
p is equal to 6,
R 1 , R 2 and R 3 , which are identical or different, are hydrogen atoms, alkyl groups comprising 1 to 3 carbon atoms, selected from methyls, ethyls, propyls, isopropyls, —NH 2 amino groups, —NH 3 + ammonium groups, or —SO 4 2− sulphate groups, said CD being alpha-cyclodextrin (α-CD) in the form of monomer.
4. The inclusion complex according to claim 1 , wherein the polysaccharide is selected from the group consisting of:
the polysaccharide is a dextran bearing hydrophobic groups, fixed by oxygen atoms of said dextran and representing groups of formula
in which
R 4 has the meanings designated above,
* represents dextran,
the polysaccharide is hyaluronic acid bearing hydrophobic groups, fixed by oxygen atoms of said hyaluronic acid and representing groups of formula
in which
R 4 has the meanings designated above,
* represents hyaluronic acid,
the polysaccharide is an amylopectin bearing hydrophobic groups fixed by oxygen atoms of said amylopectin and representing groups of formula
in which
R 4 has the meanings designated above,
* represents an amylopectin,
the polysaccharide is a pullulan bearing hydrophobic groups fixed by oxygen atoms of said pullulan and representing groups of formula
in which
R 4 has the meanings designated above,
* represents pullulan,
the polysaccharide is a heparin bearing hydrophobic groups fixed by nitrogen atoms of said heparin and representing groups of formula
in which
R 4 has the meanings designated above,
* represents heparin,
the polysaccharide is a heparin bearing hydrophobic groups fixed by oxygen atoms of said heparin, these oxygens originating from the hydroxyl or carboxyl groups of the heparin, and representing groups of formula
in which
R 4 has the meanings designated above,
* represents heparin,
the polysaccharide is a carrageenan bearing hydrophobic groups fixed by nitrogen atoms of said carrageenan sulphate and representing groups of formula
in which
R 4 has the meanings designated above,
* represents carrageenan, and
the polysaccharide is a carrageenan bearing hydrophobic groups fixed by oxygen atoms of said carrageenan, these oxygens originating from the hydroxyl or carboxyl groups of carrageenan, and representing groups of formula
in which
R 4 has the meanings designated above,
* represents carrageenan.
5. A particle with a size in the range from 1 nm to 100,000 nm containing inclusion complexes according to claim 1 .
6. An encapsulation system comprising one or more particles according to claim 5 that encapsulate a substance having pharmaceutical properties.
7. A pharmaceutical composition containing a substance having pharmaceutical properties encapsulated in the inclusion complex according to claim 1 or in particles with a size in the range from 1 nm to 100,000 nm containing said inclusion complex, together with a pharmaceutically acceptable vehicle, in solid form, or in the form of solution or suspension in a physiological medium.
8. A method for preparing an inclusion complex according to claim 1 , comprising a step of mixing at least:
one polysaccharide in the form of a suspension in a solvent, comprising hydrophobic groups bound covalently to the polysaccharide by oxygen atoms of said polysaccharide such that that said polysaccharide is amphiphilic,
and one α-cyclodextrin (CD) in the form of monomer, to obtain an inclusion complex, wherein said polysaccharide and said cyclodextrin are bound non-covalently,
wherein the polysaccharide and the cyclodextrin are present in a ratio of concentration of the cyclodextrin in g/L of the solvent to concentration of polysaccharide in g/L of the solvent in a range from 3.3 to 40, and wherein:
the polysaccharide is selected from the group consisting of chitosan, dextran, hyaluronic acid, amylose, amylopectin, pullulan, heparin, chitin, heparan sulphate, dermatan sulphate, keratan sulphate, chondroitin sulphate, cellulose sulphate, dextran sulphate, dextrin sulphate, starch, pectin, the alginates, the carrageenans, fucan, curdlan, xylan, polyglucuronic acid, xanthan, arabinan, and polymannuronic acid, said polysaccharide comprising hydrophobic groups of formula
in which
* represents the polysaccharide,
R 4 represents
a linear or branched alkyl group containing from 1 to 1000 carbon atoms,
a linear or branched alkenyl group containing 2 to 1000 carbon atoms and bearing
at least one C═C double bond,
an α-cyclodextrin (CD) having the formula
in which
p is equal to 6,
R 1 , R 2 and R 3 , which are identical or different, are hydrogen atoms, alkyl groups comprising 1 to 3 carbon atoms, selected from methyls, ethyls, propyls, isopropyls, —NH 2 amino groups, —NH 3 ammonium groups, or —SO 4 2− sulphate groups, said CD being alpha-cyclodextrin (α-CD) in the form of monomer.
9. A cosmetic composition, comprising particles according to claim 5 .
10. The inclusion complex according to claim 2 , wherein the molecular weight is equal to 20 kDa, 145 kDa or 250 kDa.
11. The inclusion complex according to claim 1 , wherein the ratio of the concentration of cyclodextrin in g/L of the solvent to that of the polysaccharide in g/L of the solvent is in the range from 4 to 15.
12. The inclusion complex according to claim 3 , wherein R4 is selected from the group consisting of —(CH 2 ) 14 —CH 3 , —(CH 2 ) 16 —CH 3 , —(CH 2 ) 7 —CH═CH—CH 2 —(CH 2 ) 7 —CH 3 and —(CH 2 ) 7 —CH═CH—(CH 2 ) 7 —CH 3 .
13. An encapsulation system comprising one or more particles according to claim 5 that encapsulate a substance having cosmetic properties.